Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMD6 antisense RNA 2 (PSMD6-AS2) is a long non-coding RNA gene located on chromosome 3, transcribed in the opposite direction to the protein-coding PSMD6 gene[6][8]. It does not produce a protein product and is not a known drug target or biomarker. PSMD6-AS2 is expressed in numerous cell types and tissues, suggesting some potential regulatory roles at the RNA level, but specific biological functions, interactions, and clinical relevance remain undefined as of current knowledge[2][4][10]. This distinguishes it from the closely related protein-coding gene PSMD6, which is implicated in cell proliferation and cancer biology[1][3], but these properties do not apply to PSMD6-AS2. There is no indication that "PSMD6 antisense RNA 2" is misspelled or incorrect as a gene name, nor is there evidence it is a structured therapeutic target in the sense of being a receptor, enzyme, transporter, or established drug target. Existing data suggests it should be classified as a "long non-coding RNA" and not a canonical therapeutic target[4][6][8].
null (no drugs targeting PSMD6-AS2, so no mechanism of action data)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PSMD6 antisense RNA 2 (PSMD6-AS2).